Home Applications 017673 Application 017673
Type NDA
Sponsor ICU MEDICAL INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AMINOSYN 5% AMINO ACIDS INJECTABLE;INJECTION 5% (5GM/100ML) No No 002 AMINOSYN 7% AMINO ACIDS INJECTABLE;INJECTION 7% (7GM/100ML) No No 003 AMINOSYN 10% AMINO ACIDS INJECTABLE;INJECTION 10% (10GM/100ML) No No 004 AMINOSYN 8.5% AMINO ACIDS INJECTABLE;INJECTION 8.5% (8.5GM/100ML) No No 005 AMINOSYN 8.5% W/ ELECTROLYTES AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE INJECTABLE;INJECTION 8.5%;102MG/100ML;522MG/100ML;410MG/100ML No No 006 AMINOSYN 7% (PH6) AMINO ACIDS INJECTABLE;INJECTION 7% (7GM/100ML) No No 007 AMINOSYN 8.5% (PH6) AMINO ACIDS INJECTABLE;INJECTION 8.5% (8.5GM/100ML) No No 008 AMINOSYN 10% (PH6) AMINO ACIDS INJECTABLE;INJECTION 10% (10GM/100ML) No No 009 AMINOSYN 8.5% W/ELECTROLYTES AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC INJECTABLE;INJECTION 8.5%;102MG/100ML;487MG/100ML;28MG/100ML;425MG/100ML No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 9 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N017673-001 AMINOSYN 5% AMINO ACIDS 5% (5GM/100ML) INJECTABLE / INJECTION Approved before 1982 N017673-002 AMINOSYN 7% AMINO ACIDS 7% (7GM/100ML) INJECTABLE / INJECTION Approved before 1982 N017673-003 AMINOSYN 10% AMINO ACIDS 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 N017673-004 AMINOSYN 8.5% AMINO ACIDS 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 N017673-005 AMINOSYN 8.5% W/ ELECTROLYTES AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE 8.5%;102MG/100ML;522MG/100ML;410MG/100ML INJECTABLE / INJECTION Approved before 1982 N017673-006 AMINOSYN 7% (PH6) AMINO ACIDS 7% (7GM/100ML) INJECTABLE / INJECTION 1985-11-18 N017673-007 AMINOSYN 8.5% (PH6) AMINO ACIDS 8.5% (8.5GM/100ML) INJECTABLE / INJECTION 1985-11-18 N017673-008 AMINOSYN 10% (PH6) AMINO ACIDS 10% (10GM/100ML) INJECTABLE / INJECTION 1985-11-18 N017673-009 AMINOSYN 8.5% W/ELECTROLYTES AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC 8.5%;102MG/100ML;487MG/100ML;28MG/100ML;425MG/100ML INJECTABLE / INJECTION 2002-10-25
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 5 of 10 · 396 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N017673-008 AMINOSYN 10% (PH6) 10% (10GM/100ML) INJECTABLE / INJECTION 1985-11-18 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N017673-009 AMINOSYN 8.5% W/ELECTROLYTES 8.5%;102MG/100ML;487MG/100ML;28MG/100ML;425MG/100ML INJECTABLE / INJECTION 2002-10-25 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N017673-001 AMINOSYN 5% 5% (5GM/100ML) INJECTABLE / INJECTION Approved before 1982 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N017673-002 AMINOSYN 7% 7% (7GM/100ML) INJECTABLE / INJECTION Approved before 1982 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N017673-003 AMINOSYN 10% 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N017673-004 AMINOSYN 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N017673-005 AMINOSYN 8.5% W/ ELECTROLYTES 8.5%;102MG/100ML;522MG/100ML;410MG/100ML INJECTABLE / INJECTION Approved before 1982 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N017673-006 AMINOSYN 7% (PH6) 7% (7GM/100ML) INJECTABLE / INJECTION 1985-11-18 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N017673-007 AMINOSYN 8.5% (PH6) 8.5% (8.5GM/100ML) INJECTABLE / INJECTION 1985-11-18 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N017673-008 AMINOSYN 10% (PH6) 10% (10GM/100ML) INJECTABLE / INJECTION 1985-11-18 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N017673-009 AMINOSYN 8.5% W/ELECTROLYTES 8.5%;102MG/100ML;487MG/100ML;28MG/100ML;425MG/100ML INJECTABLE / INJECTION 2002-10-25 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N017673-001 AMINOSYN 5% 5% (5GM/100ML) INJECTABLE / INJECTION Approved before 1982 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N017673-002 AMINOSYN 7% 7% (7GM/100ML) INJECTABLE / INJECTION Approved before 1982 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N017673-003 AMINOSYN 10% 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N017673-004 AMINOSYN 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N017673-005 AMINOSYN 8.5% W/ ELECTROLYTES 8.5%;102MG/100ML;522MG/100ML;410MG/100ML INJECTABLE / INJECTION Approved before 1982 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N017673-006 AMINOSYN 7% (PH6) 7% (7GM/100ML) INJECTABLE / INJECTION 1985-11-18 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N017673-007 AMINOSYN 8.5% (PH6) 8.5% (8.5GM/100ML) INJECTABLE / INJECTION 1985-11-18 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N017673-008 AMINOSYN 10% (PH6) 10% (10GM/100ML) INJECTABLE / INJECTION 1985-11-18 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N017673-009 AMINOSYN 8.5% W/ELECTROLYTES 8.5%;102MG/100ML;487MG/100ML;28MG/100ML;425MG/100ML INJECTABLE / INJECTION 2002-10-25 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N017673-001 AMINOSYN 5% 5% (5GM/100ML) INJECTABLE / INJECTION Approved before 1982 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N017673-002 AMINOSYN 7% 7% (7GM/100ML) INJECTABLE / INJECTION Approved before 1982 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N017673-003 AMINOSYN 10% 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N017673-004 AMINOSYN 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N017673-005 AMINOSYN 8.5% W/ ELECTROLYTES 8.5%;102MG/100ML;522MG/100ML;410MG/100ML INJECTABLE / INJECTION Approved before 1982 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N017673-006 AMINOSYN 7% (PH6) 7% (7GM/100ML) INJECTABLE / INJECTION 1985-11-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N017673-007 AMINOSYN 8.5% (PH6) 8.5% (8.5GM/100ML) INJECTABLE / INJECTION 1985-11-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N017673-008 AMINOSYN 10% (PH6) 10% (10GM/100ML) INJECTABLE / INJECTION 1985-11-18 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N017673-009 AMINOSYN 8.5% W/ELECTROLYTES 8.5%;102MG/100ML;487MG/100ML;28MG/100ML;425MG/100ML INJECTABLE / INJECTION 2002-10-25 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N017673-001 AMINOSYN 5% 5% (5GM/100ML) INJECTABLE / INJECTION Approved before 1982 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N017673-002 AMINOSYN 7% 7% (7GM/100ML) INJECTABLE / INJECTION Approved before 1982 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N017673-003 AMINOSYN 10% 10% (10GM/100ML) INJECTABLE / INJECTION Approved before 1982 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N017673-004 AMINOSYN 8.5% 8.5% (8.5GM/100ML) INJECTABLE / INJECTION Approved before 1982 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N017673-005 AMINOSYN 8.5% W/ ELECTROLYTES 8.5%;102MG/100ML;522MG/100ML;410MG/100ML INJECTABLE / INJECTION Approved before 1982 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N017673-006 AMINOSYN 7% (PH6) 7% (7GM/100ML) INJECTABLE / INJECTION 1985-11-18 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N017673-007 AMINOSYN 8.5% (PH6) 8.5% (8.5GM/100ML) INJECTABLE / INJECTION 1985-11-18 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N017673-008 AMINOSYN 10% (PH6) 10% (10GM/100ML) INJECTABLE / INJECTION 1985-11-18 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N017673-009 AMINOSYN 8.5% W/ELECTROLYTES 8.5%;102MG/100ML;487MG/100ML;28MG/100ML;425MG/100ML INJECTABLE / INJECTION 2002-10-25 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N017673-001 AMINOSYN 5% 5% (5GM/100ML) INJECTABLE / INJECTION Approved before 1982 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N017673-002 AMINOSYN 7% 7% (7GM/100ML) INJECTABLE / INJECTION Approved before 1982 782e0a99824c…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 4 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0409-4187 Aminosyn ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANI Hospira, Inc. NDA Current 0409-4191 Aminosyn ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANI Hospira, Inc. NDA Current 0409-4192 Aminosyn Sulfite Free ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANI Hospira, Inc. NDA Current 0409-4203 Aminosyn ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANI Hospira, Inc. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 13879 SUPPL 2004-05-27 13880 SUPPL 2004-03-16 679 SUPPL 2003-06-22 680 SUPPL 2003-04-15